SUMO amplifies TGF-β signalling
- 1 June 2008
- journal article
- editorial
- Published by Springer Nature in Nature Cell Biology
- Vol. 10 (6) , 635-637
Abstract
Transforming growth factor-β (TGF-β) stimulates phosphorylation of TGF-β type I receptor. This receptor is now shown to be sumoylated, leading to enhanced activation and modulation of the downstream Smad signalling pathway.Keywords
This publication has 11 references indexed in Scilit:
- The type I TGF-β receptor is covalently modified and regulated by sumoylationNature Cell Biology, 2008
- SUMOylation regulates kainate-receptor-mediated synaptic transmissionNature, 2007
- SPECIFICITY AND VERSATILITY IN TGF-β SIGNALING THROUGH SMADSAnnual Review of Cell and Developmental Biology, 2005
- Development of TGF-β signalling inhibitors for cancer therapyNature Reviews Drug Discovery, 2004
- Protein Modification by SUMOAnnual Review of Biochemistry, 2004
- GADD34–PP1c recruited by Smad7 dephosphorylates TGFβ type I receptorJournal of Cell Biology, 2004
- The two faces of transforming growth factor β in carcinogenesisProceedings of the National Academy of Sciences, 2003
- Novel inactivating mutations of transforming growth factor-? type I receptor gene in head-and-neck cancer metastasesInternational Journal of Cancer, 2001
- Smurf1 Interacts with Transforming Growth Factor-β Type I Receptor through Smad7 and Induces Receptor DegradationJournal of Biological Chemistry, 2001
- Smad7 Binds to Smurf2 to Form an E3 Ubiquitin Ligase that Targets the TGFβ Receptor for DegradationMolecular Cell, 2000